Please note that the English version of this text has been prepared with the assistance of AI, and in some instances, it may not have been subsequently reviewed or edited by the authors.
During the first operational phase of the biomedicine and photonics innovation platform “BioPhoT”, 66 Latvian innovation projects were implemented. The platform has significantly contributed to the advancement of scientific developments toward commercialization, and the average innovation readiness level of the projects increased by 4.6 points at the mid-term stage. Project teams have presented their technologies at international events, initiated cooperation with enterprises, and concluded licensing agreements, thereby creating the prerequisites for the establishment of new companies as well. At the same time, research and industry cooperation has been strengthened, 41 industry challenges have been identified, and contacts have been established with approximately 400 external partners.
On October 29, the second annual “BioPhoT” conference took place, bringing together more than 300 researchers, entrepreneurs, innovators, and other industry representatives. The results of the platform's projects and future development opportunities were presented, including nearly 40 innovation prototypes. Significant attention was also paid to the future development of the projects – so far, the average mid-term Technology Readiness Level of innovations supported by the platform has increased by 4.6 points. On average, growth is observed in three of the six readiness level components. The readiness levels for intellectual property and attracting additional funding have improved by an average of one point each. This confirms the potential of the ideas for development and commercialization. The recording of the conference is available on the “BioPhoT” platform YouTube in the channel.
“One of the most significant benefits of “BioPhoT” is the creation of closer cooperation and a shared understanding between academia and industry on how to turn scientific ideas into solutions needed by businesses and society. In the first phase of operation, out of 221 submitted projects, we have implemented 66 innovation projects. We see that with targeted support, project teams are able in a relatively short time not only to develop technological solutions, but also to find potential users and cooperation partners for them. This is an essential step on the way from a promising scientific development to a market-demanded product or technology,” points out “Osvalds Pugovičs, head of ”BioPhoT".
From scientific ideas to technology prototypes
Innovative researcher ideas supported on the platform both from the partner institutions of the “BioPhoT” platform and from other institutions – Daugavpils University, Latvia University of Life Sciences and Technologies, and Ventspils University of Applied Sciences. The range of projects is broad and interdisciplinary – biotechnology and drug development, medical technologies and biomaterials, diagnostics, monitoring and digital health, photonics and optical sensing, environmental and energy solutions, as well as advanced materials and industrial technologies.
To purposefully promote the future development of the projects, “BioPhoT”, in cooperation with the consulting firm “Civitta”, has carried out an evaluation of all 66 projects. Based on the maturity of the results achieved by the developments and their potential for further development, 27 teams have been selected, for whom the most suitable cooperation partners are currently being found. This process utilizes the methodology developed by “Civitta”, which makes it possible to tailor future cooperation opportunities to the needs of each team.
Latvian innovations attract international industry and investor interest
An essential direction of the platform's operation is to organize the establishment of contacts with potential investors and cooperation partners in the international market. The most significant was the platform's participation and project representation in one of the world's most important deep tech (deep tech) innovation events – the “Hello Tomorrow Global Summit 2026”. Representatives of ten of the most mature “BioPhoT” project teams presented their developments to more than 300 venture capital investors at the event's Investor Day.
At the same time, the platform's task is to identify the needs of the Latvian and foreign industries and connect them with research potential. In cooperation with representatives of the Latvian and foreign commercial sectors, 41 industry challenges have been identified. Their identification utilized the network of external economic representative offices of the Investment and Development Agency of Latvia, as well as photonics and life sciences clusters in France and Germany. Targeted cooperation has been implemented with 25 industry associations and chambers of commerce, including the Foreign Investors' Council in Latvia (Foreign Investors Council in Latvia), the German-Baltic Chamber of Commerce (German Chamber of Commerce Abroad), with the Latvian Chamber of Commerce and Industry, Latvian Association of Chemical and Pharmaceutical Industry, Greentech Latvia and Cleantech Latvia.
International partnerships are already delivering concrete results: German photonics industry organizations “SPECTARIS” and “OpTecBB” are promoting “BioPhoT” projects and industry challenges among their members, and “OpTecBB” has selected seven priority and three additional projects for further promotion in the German industry.
Overall, “BioPhoT” has established contacts with approximately 400 external partners, of which more than 200 are new contacts. An active dialogue has been initiated with more than 70 partners, and more than 150 partnership-building meetings have taken place. Real cooperation has been initiated in four industry challenge themes without financial support from “BioPhoT” projects, while two platform project teams have signed agreements on licensing their technologies to industry partners. Another three teams, having identified suitable and interested industry partners, have submitted applications to European Commission calls intended to support the further commercialization of developments.
Targeted support for researchers in technology commercialization
To help researchers better understand industry needs and prepare their technologies for commercialization, “BioPhoT” has implemented a special training program. It includes personalized commercialization coaching for project teams, in-depth training on commercialization principles and the fundamentals of technology transfer, as well as knowledge of regulatory requirements and opportunities for attracting additional funding. This approach allows researchers to evaluate the practical application, market potential, and future growth opportunities of their innovations at an early stage of development.
The experience gained in the first phase of operations will allow, in the next development phase, to further adapt support to the needs of the projects by improving the project selection and results evaluation approach and by introducing incubation programs suitable for each team. Particular attention will be paid to building cooperation with the industry, attracting further funding and investment, and opportunities for technology commercialization.
“Innovation takes time. Depending on the technology and market situation, it can take several years from an idea to commercial success. Therefore, the task of “BioPhoT” is not only to provide initial funding, but also to help teams as effectively as possible prepare for the next stages of development, find suitable industry partners, and attract the necessary investments, emphasizes Osvalds Pugovičs.
“BioPhoT is a long-term initiative aimed at ensuring research continuity, helping prospective projects reach subsequent development stages, strengthening existing companies, and promoting the creation of new businesses, including spin-off companies from research institutions. The platform is planned with an eight-year perspective, providing for the availability of funding in 2027–2032 depending on the achieved results.
“Biomedical and Photonics Research Platform for the Creation of Innovative Products” (“BioPhoT”) is implemented under the leadership of the National Institute of Research and Innovation, by the Institute of Electronics and Computer Science, University of Latvia, Institute of Solid State Physics of the University of Latvia, Latvian State Institute of Wood Chemistry, Food Safety, Animal Health and Environmental Science “BIOR”, Riga Stradins University and Riga Technical University.
Project No. IVPP-EM-Inovācija-2024/1-0002 “Biomedicine and Photonics Research Platform for the Creation of Innovative Products (BioPhoT)” is implemented within the framework of the long-term state research programme “Innovation Fund – Long-Term Research Programme”, funded by the Ministry of Economics.
